Oxytocin Signalling Studies: hOTR BRET and HUVEC Spheroid Records

Research use only. The cited studies describe cellular experimental systems and do not provide human or veterinary use, dosing, administration, safety, or outcome guidance.

Two oxytocin studies use different cellular systems

PMID 22069312 and PMID 19563802 both concern oxytocin-receptor signalling, but they do not use the same model or readouts. The first reports bioluminescence resonance energy transfer measurements at the human oxytocin receptor. The second reports a three-dimensional in vitro assay using human umbilical-vein endothelial-cell spheroids. Their measurements remain attached to their respective systems.

Which model and readouts does PMID 22069312 report?

Busnelli et al. (2012; PMID 22069312) used bioluminescence resonance energy transfer biosensors to screen ligands at the human oxytocin receptor. The PubMed record identifies oxytocin and selected peptidic analogues in this receptor system. The reported assay endpoints include engagement and activation of Gq and Gi/o-family subtypes, beta-arrestin recruitment, and receptor internalization.

These are receptor-signalling measurements in the authors’ biosensor experiment. PMID 22069312 does not identify an endothelial-cell spheroid system, a tissue-level measurement, or the identity or analytical properties of a catalogue lot.

Which model and readouts does PMID 19563802 report?

Cattaneo et al. (2009; PMID 19563802) used a three-dimensional in vitro angiogenesis assay with human umbilical-vein endothelial-cell spheroids. The abstract describes capillary-like outgrowth as comparable to vascular endothelial growth factor and describes pharmacological inhibitors of phospholipase C, phosphatidylinositol 3-kinase, and Src kinase, together with Pyk-2 RNA interference.

The reported readouts include capillary-like outgrowth from spheroids, Pyk-2 and Src phosphorylation, cell migration, and endothelial sprouting. These are measurements in the stated HUVEC assay. This citation does not report the human-oxytocin-receptor BRET endpoints from PMID 22069312.

Why the two records cannot be combined

PMID 22069312 addresses ligand-dependent receptor-signalling measurements at the human oxytocin receptor. PMID 19563802 addresses a HUVEC spheroid assay with pharmacological and RNA-interference comparisons. A pathway name shared by two papers does not make their models, comparators, or readouts interchangeable. Neither source establishes the identity, composition, purity, manufacture, or performance of another catalogue batch.